Literature DB >> 7929235

Protein expression using cotranslational fusion and cleavage of ubiquitin. Mutagenesis of the glutathione-binding site of human Pi class glutathione S-transferase.

R T Baker1, S A Smith, R Marano, J McKee, P G Board.   

Abstract

Expression of cloned genes in prokaryotes such as Escherichia coli is a widely used technique in both basic research and biotechnology. Despite the availability of several E. coli expression vector systems, adequate levels of expression may not be achieved. Expressing proteins as fusions to the highly conserved eukaryotic protein ubiquitin has been reported by several investigators to enhance protein yield in both bacterial and eukaryotic systems. We have modified this technique by the co-expression in E. coli of a ubiquitin-fusion protein and the Saccharomyces cerevisiae ubiquitin-specific protease Ubp2. This allows the co-translational cleavage of engineered ubiquitin-fusion proteins expressed in E. coli. This system was used to express a human Pi class glutathione S-transferase (GST) GSTP1 as well as two mutant GSTP1 derivatives, Trp39-->Cys and Gln52-->Glu. The yield of these enzymes was improved 40-fold by using the ubiquitin-fusion/co-translational cleavage technique, and no uncleaved product was detected. The Trp39-->Cys mutant was totally devoid of GST activity, while the activity of the Gln52-->Glu mutant was reduced to 6% of wild-type GSTP1-1. As both of the mutated residues map within the glutathione-binding site, the reduced GST activity is consistent with a marked reduction in glutathione binding ability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929235

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Authors:  Ann-Maree Catanzariti; Tatiana A Soboleva; David A Jans; Philip G Board; Rohan T Baker
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

2.  Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity.

Authors:  Jamie J Arnold; Alejandro Bernal; Uzo Uche; David E Sterner; Tauseef R Butt; Craig E Cameron; Michael R Mattern
Journal:  Anal Biochem       Date:  2005-11-17       Impact factor: 3.365

Review 3.  Strategies for the identification of novel inhibitors of deubiquitinating enzymes.

Authors:  Seth J Goldenberg; Jeffrey L McDermott; Tauseef R Butt; Michael R Mattern; Benjamin Nicholson
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

4.  Sequencing and expression of a cDNA for human glutathione synthetase.

Authors:  R R Gali; P G Board
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

5.  High-yield production in E. coli and characterization of full-length functional p13II protein from human T-cell leukemia virus type 1.

Authors:  Elka R Georgieva; Peter P Borbat; Christina Fanouraki; Jack H Freed
Journal:  Protein Expr Purif       Date:  2020-04-30       Impact factor: 1.650

6.  Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4-4.

Authors:  P G Board
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Mutagenesis of the active site of the human Theta-class glutathione transferase GSTT2-2: catalysis with different substrates involves different residues.

Authors:  K L Tan; G Chelvanayagam; M W Parker; P G Board
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

8.  Purification and characterization of a recombinant human Theta-class glutathione transferase (GSTT2-2).

Authors:  K L Tan; P G Board
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 9.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

10.  Chaperoning ribosome assembly.

Authors:  Katrin Karbstein
Journal:  J Cell Biol       Date:  2010-04-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.